The objective of this call is to promote the transfer of knowledge in the Autonomous Community of Cantabria, understanding knowledge transfer as the set of activities aimed at the dissemination of knowledge, experience and skills in order to facilitate the use, application and exploitation of knowledge and capabilities in R&T of the university and research centers outside the academic environment, either by other R&T institutions, the productive sector or society in general.

The maximum amount of the call is 200,000 euros.

The grant will be awarded for the amount corresponding to the cost of the actions that are accredited as necessary for the proper implementation of the project, with a maximum limit of 20,000 euros per project.

Beneficiaries

Public companies, public business entities and foundations attached to or dependent on the Autonomous Community of Cantabria, as well as any other entity belonging to the autonomous public sector of the Autonomous Community of Cantabria, which are in the situation that justifies the granting of the subsidy.

The purpose of the subsidies is to provide economic assistance to public entities that promote the transfer of knowledge.

This knowledge transfer can adopt any of the following modalities:

– Transfer of knowledge derived from the realization of Final Degree, Final Master or Industrial Doctorate works of interest for the end user of the knowledge transfer.

– Transfer of knowledge derived from the realization of collaborative Research Projects between the agent that develops the knowledge and the potential end user of the same.

Documentation

The application shall be accompanied by the Descriptive Report of the Project according to the model that will be published as an Annex together with the call, as well as an estimated list of eligible expenses corresponding to the period to which the call refers, also formalized in the official model that will be published as an Annex to the respective call.

The application shall be accompanied by an Annex-Responsible declaration in accordance with the model that will be published together with the call for applications.

The application shall be accompanied by an estimate of eligible expenses corresponding to the period to which the call refers, in accordance with the model of Annex-Estimation of eligible expenses that will be published together with the call.

25

The applications must be signed by the representative of the entity, formalized in the official model that is published in the Annex in the call.

Applications may be submitted up to one month from the day following the publication of this extract of this call in the Official Gazette of Cantabria (25/05/2023).

Applications may be submitted at the Common Electronic Register https://rec.cantabria.es/rec/bienvenida.htm or at cBOC Cantabria (25/05/2023)

Orden UIC/9/2023, de 19 de abril, por la que se establecen las bases reguladoras para la concesión de subvenciones para el fomento de la transferencia de conocimiento destinadas a entidades públicas en la Comunidad Autónoma de Cantabria, publicada en BOC de 4/05/2023 (enlace)

Call for the promotion of knowledge transfer for public entities in Cantabria

The objective of this call is to promote the transfer of knowledge in the Autonomous Community of Cantabria, understanding knowledge transfer as the set of activities aimed at the dissemination of knowledge, experience and skills in order to facilitate the use, application and exploitation of knowledge and capabilities in R&T of the university and research […]



An opportunity to train and gain experience in research management in a health institute accredited by the Instituto de Salud Carlos III.

The GES-VAL program for the training of research managers aims to promote the professional practice and training of technicians in aspects related to the management and support of research, by learning aspects related to the management, monitoring and evaluation of research promotion activities, as well as internationalization and innovation activities in the field of health sciences and technologies.

1 temporary employment contract is announced for the development of activities in the field of research management in the scientific production unit of the Institute. An opportunity to get to know the IDIVAL Institute, its organization and management, developing functions related to the management and updating of the Institute’s scientific production databases. The research portal is a fundamental tool that makes the Institute’s research visible at national and international level. Among other functions to be developed will be to support in the updating of information systems in the bibliometric field, exploitation of information systems and the database for the preparation of documentation, reports and scientific production reports and contact with researchers to advise them and provide support in the field of scientific production.

The internship contract will have a duration of 12 months, counting from the date of incorporation, the trial period will be two months. The selected candidate will develop a tutored training itinerary, with periodic evaluations and presentation of a report at the end of the first year.

Requisitos de los candidatos

First cycle university graduates are eligible for the Ges-Val program. In all cases, these must be official Spanish degrees and, if they have been obtained abroad, they must be officially recognized on the date of the deadline for submitting applications, in accordance with the applicable regulations.

The contract may be entered into with those in possession of the required university degree, provided that no more than five years have elapsed, or seven, when the contract is entered into with a disabled worker, from the completion of the studies to the start of the contract, and that they have not previously entered into another internship contract in possession of the same degree.

Required documentation

Together with the application, applicants must submit the following documentation:

a) Curriculum vitae in CVA format

Standardized curriculum vitae reduced version FECYT, available at: https://cvn.fecyt.es/ and on the IDIVAL intranet.

b) Report of the proposal of the activities to be carried out by the candidate.

It should reflect the candidate’s interests and include general references to the different IDIVAL support areas, with a more detailed description of those that adapt to the candidate’s profile and interests: project area, training and methodological support area, clinical trials area, technological services area, innovation area and general services area. For the purposes of the evaluation process, only the information contained in the corresponding curriculum vitae and reports will be taken into account on the closing date of the application submission period. Failure to submit these within the deadline will not be correctable and will result in the exclusion of the application during the admission phase.

c) Copy of the DNI.

d) Official academic certification of the studies completed, with details of the subjects taken and the grades obtained, and, where appropriate, a copy of the academic degree.

e) Documentary accreditation of the curricular merits provided (certificate of employment, credentials of the candidate, course certificates stating the duration of the same, etc.), without which requirement they will not be taken into consideration.

 

Submission of applications until June 17

Solicitudes: https://aplicacionesidival.idival.org/ConvocatoriasPropias/es/Convocatorias/VerConvocatoria?Id=1009

Extraordinary call for research managers training program GES-VAL open until June 17

An opportunity to train and gain experience in research management in a health institute accredited by the Instituto de Salud Carlos III. The GES-VAL program for the training of research managers aims to promote the professional practice and training of technicians in aspects related to the management and support of research, by learning aspects related […]


An excellent opportunity to train in the clinical trials unit of Hospital Valdecilla, a reference unit in clinical trials in northern Spain, which has a team of highly experienced professionals.

In the ordinary call TEC-VAL has been a vacancy so this program is reconvened with the same rules as the previous one.

The training program for research support technicians Valdecilla “TEC-VAL” is a training program that promotes professional practice and training of technicians in aspects related to research support in the field of various support services platforms IDIVAL, which in this call 2023 are specifically directed to the Clinical Trials Unit Valdecilla.

The internship contract will have a duration of 12 months, counting from the date of incorporation. The selected candidate will develop a tutored training itinerary, with periodic evaluations and presentation of a report at the end of the first year.

The TEC-Val program is open to first cycle university graduates. In all cases, these must be official Spanish degrees and, if they have been obtained abroad, they must be officially recognized on the date of the deadline for submitting applications, in accordance with the applicable regulations.

The contract may be entered into with those in possession of the required degree, provided that no more than five years have elapsed, or seven, when the contract is entered into with a disabled worker, since the completion of the studies and that they have not previously accessed another internship contract while in possession of the same degree.

Documentation to be submitted:

Together with the application, applicants must submit the following documentation:

a) Curriculum vitae in CVA format

Standardized curriculum vitae in reduced version FECYT, available at: https://cvn.fecyt.es/ and on the IDIVAL intranet.

b) Report of the proposed activities to be carried out by the candidate.

It should include a proposal of the activities to be carried out by the candidate and include general references to the different support services units of IDIVAL, with a more detailed description of those that fit the profile and interests of the candidate: referred to the clinical trials unit or the technological services (biobank or microscopy unit) IDIVAL. For the purposes of the evaluation process, only the information contained in the corresponding curriculum vitae and reports will be taken into account on the closing date of the application submission period. Failure to submit these documents by the deadline will not be correctable and will result in the exclusion of the application during the admission phase.

c) Copy of the DNI.

d) Official academic certification of the studies completed, with details of the subjects taken and grades obtained, and, where appropriate, a copy of the academic degree. corresponding sworn translation.

e) Documentary accreditation of the curricular merits provided (certificate of employment, credentials of the candidate, course certificates stating the duration of these, etc.), without which requirement they will not be taken into consideration.

 

Submission of applications: until June 17.

 

Application: https://aplicacionesidival.idival.org/ConvocatoriasPropias/es/Convocatorias/VerConvocatoria?Id=1008

 



The results of the latest study will allow progress to be made in the design of specific strategies for the management of cardiovascular risk according to sex.

The ‘Immunopathology’ group of the Marqués de Valdecilla Health Research Institute (IDIVAL) coordinates a multicenter study with a dozen Spanish hospitals to investigate cardiovascular risk in patients with axial spondyloarthritis, a disease characterized by inflammation of the sacroiliac joints and the spine with severe pain, stiffness and fatigue.

The results of the latest study describe for the first time the differences associated with sex in the cardiovascular profile, specifically in atherosclerosis, known as “hardening of the arteries”, which can completely obstruct vessels with the formation of plaques inside them.

An in-depth understanding of axial spondyloarthritis and its cardiovascular profile is the first step towards establishing specific strategies for managing cardiovascular risk according to sex, as well as delving into ailments such as chronic inflammatory arthropathies in which there is destruction of a joint as a result of inflammation.

The authors confirmed that disease-specific factors such as inflammatory burden and functional and mobility limitations are associated with atherosclerosis in both men and women.

However, the interaction between inflammation, classical risk factors and atherosclerosis is closer in the case of women.

The results were obtained after analyzing data on the disease itself, classical risk factors and subclinical atherosclerosis obtained by carotid ultrasound in 611 men and 301 women from the AtheSpAin cohort.

The authors aim to further explore this field and studies are already underway to analyze the impact that inflammation may have on various parameters of cardiovascular risk according to the sex of the patients.

Reference: Ferraz-Amaro I, Genre F, Blanco R, Corrales A, Mazón IG, Portilla V, Aurrecoechea E, Mata C, Hernández-Hernández V, Quevedo-Abeledo JC, Rodríguez-Lozano C, Lopez-Medina C, Ladehesa-Pineda ML, Castañeda S, Vicente EF, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Vivar MLG, Galíndez-Agirregoikoa E, Vegas-Revenga N, Urionagüena-Onaindia I, Perez EM, Díaz CF, González-Gay MÁ, Rueda-Gotor J. Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients. Semin Arthritis Rheum. 2023 Jun;60:152198. doi: 10.1016/j.semarthrit.2023.152198. Epub 2023 Mar 29. PMID: 37058848.

IDIVAL leads a multicenter study on axial spondyloarthritis disease

The results of the latest study will allow progress to be made in the design of specific strategies for the management of cardiovascular risk according to sex. The ‘Immunopathology’ group of the Marqués de Valdecilla Health Research Institute (IDIVAL) coordinates a multicenter study with a dozen Spanish hospitals to investigate cardiovascular risk in patients with […]


Artificial intelligence, intra-entrepreneurship and big data were some of the key topics of the ` I National Forum on Innovation Management in Healthcare

The Marqués de Valdecilla Health Research Institute (IDIVAL) together with the Ministry of Health of the Government of Cantabria organized on April 28 the 1st National Forum on Innovation Management in Healthcare `MIND THE GAP’ which was attended by around 200 people from all over Spain and was sponsored by Janssen and supported by the Botín Foundation and the ITEMAS Platform.

The aim of this conference, which was open to companies, innovation and research managers, clinicians, managers and executives, was to discuss organizational innovation, focused on patients, knowledge and healthcare technologies. Artificial intelligence, intrapreneurship, big data or innovative public procurement were some of the key topics that were discussed in round table format at the Botín Foundation in Santander.

The coordinators of this meeting have valued this conference “as an excellent opportunity to establish synergies and collaborations between the different agents in the health innovation management environment, which aims to consolidate itself as a national reference forum”.

The conference was inaugurated by the Minister of Health, Raúl Pesquera, the Deputy Director General of Networks and Corporate Research Centers of the Carlos III Health Institute, Agustín González, and Ana Isabel Gil, representing the patients.

Also, the master conference ‘Precision Medicine, new realities, new challenges’ was given by Dr. Ángel Carracedo, director of the Foundation of Xenomic Medicine-SERGAS and Professor of Legal Medicine at the University of Santiago.

Los ponentes de esta jornada forman parte del Máster en Dirección y Gestión de la Innovación en Salud (MINDS) coordinado por IDIVAL y la Universidad Nebrija y que tiene como objetivo generar una red de profesionales del ámbito sanitario y de la empresa que puedan promover el desarrollo de la innovación en salud en su entorno.

The speakers at this conference are part of the Master in Management and Administration of Innovation in Healthcare (MINDS) coordinated by IDIVAL and Nebrija University, which aims to create a network of professionals from the healthcare and business fields who can promote the development of innovation in healthcare in their environment.

Registration open for the II Edition of the Master in Management and Management of Innovation in Health (MINDS)

IDIVAL and Nebrija University have opened registration for the second edition of the Master’s program, which is once again sponsored by Janssen and supported by the Botín Foundation. Those interested may also apply for one of the available tuition scholarships.

Through meetings with expert speakers from the fields of research, health, management and entrepreneurship, who will give a practical vision of their field, the participating students will acquire knowledge for the analysis, understanding, development and leadership of innovative projects in the public and private sectors. For this reason, both the faculty and the participating students have an interdisciplinary profile from teaching, management, technical or clinical fields.

Visits to the main innovation centers in the country and specific events will complement the program in order to learn first-hand about the management and progress of innovation.

With a hybrid format, online and face-to-face at the Botín Foundation in Madrid, the sessions will begin in September 2023 and will last until June 2024, during which the different works elaborated by the students will be presented.

Additional information on registration, programming and available scholarships can be found on the mindsmaster.org website or by contacting minds@idival.org.

Around 200 people from all over Spain debated innovation in the field of healthcare

Artificial intelligence, intra-entrepreneurship and big data were some of the key topics of the ` I National Forum on Innovation Management in Healthcare The Marqués de Valdecilla Health Research Institute (IDIVAL) together with the Ministry of Health of the Government of Cantabria organized on April 28 the 1st National Forum on Innovation Management in Healthcare […]



The Council of Ministers has approved this Wednesday the call 2023 of the ATRAE program specifically aimed at attracting R4 researchers, the highest echelon of a consolidated scientific career, to our universities and public research organizations.

This program will serve to hire a minimum of 25 PhDs with more than seven years of postdoctoral experience to develop their line of research in Spain. This call contemplates the possibility of increasing the endowment by 5 million more, up to 30 million, if the budget is available.

Research personnel eligible for these grants must have more than seven years of postdoctoral experience and have carried out their activity abroad for at least 5 of the last 7 years. The beneficiary research leaders will receive a grant of up to one million euros to develop their line of research in Spain.

This investment will serve to make our country and our public funding system more competitive to pay the salary of these researchers -which will be a minimum of 80,000 euros per year-, to hire the necessary research personnel to form their research group and for the acquisition of equipment and adaptation of spaces for the establishment of their group.

The aid will be requested by the researcher, who must have a letter of acceptance from the organization he/she intends to join and a commitment of consolidation. The contract will be for an initial duration of three to four years and the beneficiary will be the host institution.

Approved the call 2023 of the ATRAE program specifically aimed at attracting R4 researchers

The Council of Ministers has approved this Wednesday the call 2023 of the ATRAE program specifically aimed at attracting R4 researchers, the highest echelon of a consolidated scientific career, to our universities and public research organizations. This program will serve to hire a minimum of 25 PhDs with more than seven years of postdoctoral experience […]


Francisco Sánchez Madrid, member of IDIVAL’s External Council and Head of the Immunology Service of the Hospital Universitario de La Princesa has received the Robert Koch Award 2023. The immunologist and professor at Harvard University in Boston, Timothy Springer, has also been awarded this prize for their important joint research in Immunology.

Both were pioneers in discovering the relevance of cell adhesion molecules in immune cell function. This important finding has opened up new possibilities for the treatment of immune diseases using monoclonal antibodies.

The Robert Koch Prize is endowed with 120,000 euros, is considered one of the most important scientific prizes in Germany, and is awarded annually by the Robert Koch Foundation and the German Ministry of Health.

The Robert Koch Award ceremony will take place on November 17, 2023 in the city of Berlin. Francisco Sánchez Madrid and Timothy Springer will receive the award from the Nobel Laureate in Medicine, Professor Jules Hoffmann.

Alongside Professors Francisco Sánchez Madrid and Timothy Springer, Professor Patrice Courvalin, one of the world’s most renowned researchers in the field of antibiotic resistance, will receive the Robert Koch Gold Medal.

Francisco Sánchez Madrid

He is head of the Immunology Service of the Hospital Universitario de La Princesa, director of the Instituto de Investigación Sanitaria IIS Princesa, Professor of Immunology at the Universidad Autónoma de Madrid and member of the IDIVAL External Council that provides scientific advice to the Institute and is composed of people in the field of health sciences of recognized prestige in the scientific community. In addition, Professor Francisco Sánchez Madrid is also currently the director of the Intercellular Communication in the Inflammatory Response group at the National Center for Cardiovascular Research (CNIC).

Dr. Sánchez obtained his PhD from the Universidad Autónoma de Madrid in 1980. After his doctoral thesis, he moved to the Department of Pathology at Harvard Medical School in Boston, Massachusetts. It was then that, together with Professor Timothy Springer, they identified the integrins that control the adhesion and activation of leukocytes and thus made a decisive contribution to the development of therapies for inflammatory and autoimmune diseases, such as multiple sclerosis and Crohn’s disease.

Their subsequent research has made a decisive contribution to understanding the function of immune synapses, i.e. the structures by which immune cells communicate with each other or with other cells. This work is instrumental in unraveling the immune system and its role in the immune response in health and disease.